Aller au contenu
Force et musclesRevue des preuves3 min read

Grip-strength tests for sarcopenia and frailty are done too differently to compare

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Differences in handgrip strength protocols to identify sarcopenia and frailty - a systematic review. · BMC geriatrics · 2017 · Article original ↗

À retenir

A systematic review of 72 studies that used handgrip strength to diagnose sarcopenia (37 studies) or frailty (33 studies; 2 covered both) found that most gave limited information about the test protocol. The authors conclude that high protocol heterogeneity makes comparison across studies very difficult. It is a review of methods, not of how well grip tests work.

Study design

Revue des preuves

Reading basis

Published abstract

Reading focus

Design & applicability

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Handgrip strength (HGS) is used to diagnose sarcopenia and frailty, but many factors affect the number a person scores. If studies measure grip differently, they may flag different people as weak. The authors set out to collect the studies that measured HGS for these diagnoses and identify how their protocols differ.

Population et méthode

Systematic review following the PRISMA statement. PubMed and Web of Science were searched up to August 16, 2016. The authors summarised the evidence on HGS measurement protocols used to diagnose sarcopenia and frailty and compared the most recent protocols for the procedure. The abstract does not report quality assessment or which protocol details were compared.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    The search identified 4393 articles, and 72 studies were included: 37 on sarcopenia, 33 on frailty and 2 that evaluated both.
  2. 2
    Most studies gave limited information about their HGS protocol, and the majority did not describe a complete measurement procedure.
  3. 3
    Protocols varied widely among sarcopenia and frailty studies, making comparative conclusions across studies very difficult.

Limites et incertitude

  1. 1
    Only two databases were searched, so relevant studies may be missing.
  2. 2
    The review describes reporting and methods, not whether protocol differences change who is classified as weak; the authors say this may be the case.
  3. 3
    The abstract lists no specific protocol details, so the exact sources of variation cannot be judged.
  4. 4
    The search ended in August 2016, so later protocol recommendations are not covered.

Mise en perspective

Grip strength cut-offs from different studies may not be directly comparable because the way it was measured differs and is often incompletely described. A single number from one test is not a diagnosis. If your clinician checks your grip strength, ask that it be done the same way each time.

Vos données

If you own a grip dynamometer, use the same device, posture, arm and time of day, and compare your own readings over time rather than with published cut-offs. Grip strength is not recorded by common wearables, and a diagnosis of sarcopenia or frailty needs a clinician.

Comprendre ce type de preuve

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Hand grip strength (HGS) is used for the diagnosis of sarcopenia and frailty. Several factors have been shown to influence HGS values during measurement. Therefore, variations in the protocols used to assess HGS, as part of the diagnosis of sarcopenia and frailty, may lead to the identification of different individuals with low HGS, introducing bias. The aim of this systematic review is to gather all the relevant studies that measured HGS to diagnose sarcopenia and frailty and to identify the differences between the protocols used.

Methods

A systematic review was carried out following the recommendations of The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement. PubMed and Web of Science were systematically searched, until August 16, 2016. The evidence regarding HGS measurement protocols used to diagnose sarcopenia and frailty was summarised and the most recent protocols regarding the procedure were compared.

Results

From the described search 4393 articles were identified. Seventy-two studies were included in this systematic review, in which 37 referred to sarcopenia articles, 33 to frailty and two evaluated both conditions. Most studies presented limited information regarding the protocols used.

Conclusions

The majority of the studies included did not describe a complete procedure of HGS measurement. The high heterogeneity between the protocols used, in sarcopenia and frailty studies, create an enormous difficulty in drawing comparative conclusions among them.

Sources et attribution

Differences in handgrip strength protocols to identify sarcopenia and frailty - a systematic review.

Sousa-Santos AR, Amaral TF.

BMC geriatrics · 2017-10-16

DOI: 10.1186/s12877-017-0625-y ↗PubMed · 29037155 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Synthèse de revues

ACSM review of 137 reviews: resistance training works, and few programme details matter

The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.

Medicine & Science in Sports & Exercise

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Nearly every resistance training plan beat no exercise; heavy loads led for strength

In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
·Méta-analyse observationnelle

Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes

Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Protein supplements and weight training: small extra gains, smaller in older adults

Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
Force et muscles →